启明医疗-B(02500)：Cardiovalve Ltd.与MTH IP, L.P.就美国第385号专利对Edwards提起专利侵权诉讼

智通财经01-22

智通财经APP讯，启明医疗-B(02500)发布公告，于2025年6月9日，美国联邦巡回上诉法院作出判决，确认由Cardiovalve Ltd.拥有的美国专利第10,702,385号(心脏瓣膜植入物)(美国第385号专利)中若干权利要求具专利有效性，而Edwards Lifesciences Corp.及Edwards Lifesciences LLC(统称“Edwards”)曾于2021年六月在...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2605459250?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-22 12:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2605459250","market":"sh","top_or_hot":-1,"title":"启明医疗-B(02500)：Cardiovalve Ltd.与MTH IP, L.P.就美国第385号专利对Edwards提起专利侵权诉讼","media":"智通财经","content":"<div>\n<p>智通财经APP讯，启明医疗-B(02500)发布公告，于2025年6月9日，美国联邦巡回上诉法院作出判决，确认由Cardiovalve Ltd.拥有的美国专利第10,702,385号(心脏瓣膜植入物)(美国第385号专利)中若干权利要求具专利有效性，而Edwards Lifesciences Corp.及Edwards Lifesciences LLC(统称“Edwards”)曾于2021年六月在...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1396024.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>启明医疗-B(02500)：Cardiovalve Ltd.与MTH IP, L.P.就美国第385号专利对Edwards提起专利侵权诉讼</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n启明医疗-B(02500)：Cardiovalve Ltd.与MTH IP, L.P.就美国第385号专利对Edwards提起专利侵权诉讼\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-22 12:13 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1396024.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，启明医疗-B(02500)发布公告，于2025年6月9日，美国联邦巡回上诉法院作出判决，确认由Cardiovalve Ltd.拥有的美国专利第10,702,385号(心脏瓣膜植入物)(美国第385号专利)中若干权利要求具专利有效性，而Edwards Lifesciences Corp.及Edwards Lifesciences LLC(统称“Edwards”)曾于2021年六月在...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1396024.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MTH","symbol_name":"Meritage Homes Corp","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1396024.html","article_id":"2605459250","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2605459250","pubTimestamp":1769055189,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，启明医疗-B 发布公告，于2025年6月9日，美国联邦巡回上诉法院作出判决，确认由Cardiovalve Ltd.拥有的美国专利第10,702,385号中若干权利要求具专利有效性，而Edwards Lifesciences Corp.及Edwards Lifesciences LLC曾于2021年六月在专利双方复审程序中对该专利提出质疑。于2026年1月14日，Cardiovalve Ltd.与MTH IP, L.P.就美国第385号专利于美国特拉华州地区法院对Edwards提起专利侵权诉讼，指控Edwards的核心产品PASCAL Precision经导管瓣膜修复系统侵犯Cardiovalve Ltd.所持有的美国第385号专利。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"91348":"深圳市道通科技股份有限公司（临时代码）","MTH":"Meritage Homes Corp","BK4588":"碎股","BK4136":"纸材料包装","BK4585":"ETF&股票定投概念","BK1574":"生物医药B类股","02500":"启明医疗-B","BK1100":"医疗保健设备","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","LU2463526074.USD":"NORDEA 1 - GLOBAL CLIMATE ENGAGEMENT \"BP\" (USD) ACC","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","IP":"国际纸业","BK1583":"高瓴概念","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","LU1481599808.USD":"THREADNEEDLE (LUX) UK EQUITY INCOME \"AUC\" (USDHDG) INC","LU1481600234.SGD":"THREADNEEDLE (LUX) UK EQUITY INCOME \"ASC\" (SGDHDG) INC","LU1487256676.USD":"THREADNEEDLE (LUX) UK EQUITY INCOME \"ZUH\" (USDHDG) ACC","BK4088":"住宅建筑"},"translate_title":"Qiming Medical-B (02500): Cardiovalve Ltd. files patent infringement lawsuit against Edwards with MTH IP, L.P. over U.S. Patent No. 385","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"91348":1.5,"MTH":1.5,"IP":1.5,"02500":1.5},"content_text":"智通财经APP讯，启明医疗-B(02500)发布公告，于2025年6月9日，美国联邦巡回上诉法院作出判决，确认由Cardiovalve Ltd.拥有的美国专利第10,702,385号(心脏瓣膜植入物)(美国第385号专利)中若干权利要求具专利有效性，而Edwards Lifesciences Corp.及Edwards Lifesciences LLC(统称“Edwards”)曾于2021年六月在专利双方复审程序中对该专利提出质疑。于2026年1月14日，Cardiovalve Ltd.与MTH IP, L.P.就美国第385号专利于美国特拉华州地区法院对Edwards提起专利侵权诉讼，指控Edwards的核心产品PASCAL Precision经导管瓣膜修复系统侵犯Cardiovalve Ltd.所持有的美国第385号专利。由于诉讼仍处于初步阶段，进一步详情(包括可能索偿金额)仍须视诉讼结果而定。公司将根据香港联合交易所有限公司证券上市规则的规定于适当时候就诉讼的任何实质进展作出进一步公告。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2605459250","isCrawlerRequest":true}